Option Care Health, Inc.
OPCH
주식 순위
#3625
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
주가
$31.32
마지막 동기화: 2026-10-20
시가총액
$4.69B
변동 (1일)
0.34%
변동 (1년)
11.01%
국가
US
거래 Option Care Health, Inc. (OPCH)
카테고리
Healthcare
Option Care Health, Inc. (OPCH)의 매출
Jun 2026 기준 매출 TTM: $5.69B
Option Care Health, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $5.69B입니다. 2023년에 회사는 $4.30B의 수익을 올렸으며 이는 2022년의 $3.94B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Option Care Health, Inc.의 수익 기록 (2000 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $5.69B | 13.91% |
| 2024 | $5.00B | 16.17% |
| 2023 | $4.30B | 9.06% |
| 2022 | $3.94B | 14.72% |
| 2021 | $3.44B | 13.39% |
| 2020 | $3.03B | 31.26% |
| 2019 | $2.31B | 19.11% |
| 2018 | $1.94B | 137.37% |
| 2017 | $817.19M | -12.66% |
| 2016 | $935.59M | -4.75% |
| 2015 | $982.22M | 6.46% |
| 2014 | $922.65M | 32.48% |
| 2013 | $696.47M | 17.36% |
| 2012 | $593.45M | 7.02% |
| 2011 | $554.51M | 28.74% |
| 2010 | $430.71M | -67.60% |
| 2009 | $1.33B | -5.16% |
| 2008 | $1.40B | 17.05% |
| 2007 | $1.20B | 3.98% |
| 2006 | $1.15B | 7.37% |
| 2005 | $1.07B | 70.16% |
| 2004 | $630.52M | 7.09% |
| 2003 | $588.77M | 2.11% |
| 2002 | $576.60M | 26.27% |
| 2001 | $456.65M | 35.03% |
| 2000 | $338.17M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $78.01B | 1,270.21% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 283.10% |
US
|
|
| $3.89B | -31.59% |
SA
|
|
| $11.08B | 94.69% |
BR
|
